Abstract:Background: The prognosis for many cancers could be improved dramatically if they could be detected while still at the microscopic disease stage. It follows from a comprehensive statistical analysis that a number of antigens such as hTERT, PCNA and Ki-67 can be considered as cancer markers, while another set of antigens such as P27KIP1 and FHIT are possible markers for normal tissue. Because more than one marker must be considered to obtain a classification of cancer or no cancer, and if cancer, to classify it as malignant, borderline, or benign, we must develop an intelligent decision system that can fullfill such an unmet medical need.Results: We have developed an intelligent decision system using machine learning techniques and markers to characterize tissue as cancerous, non-cancerous or borderline. The system incorporates learning techniques such as variants of support vector machines, neural networks, decision trees, self-organizing feature maps (SOFM) and recursive maximum contrast trees (RMCT). These variants and algorithms we have developed, tend to detect microscopic pathological changes based on features derived from gene expression levels and metabolic profiles. We have also used immunohistochemistry techniques to measure the gene expression profiles from a number of antigens such as cyclin E, P27KIP1, FHIT, Ki-67, PCNA, Bax, Bcl-2, P53, Fas, FasL and hTERT in several particular types of neuroendocrine tumors such as pheochromocytomas, paragangliomas, and the adrenocortical carcinomas (ACC), adenomas (ACA), and hyperplasia (ACH) involved with Cushing's syndrome. We provided statistical evidence that higher expression levels of hTERT, PCNA and Ki-67 etc. are associated with a higher risk that the tumors are malignant or borderline as opposed to benign. We also investigated whether higher expression levels of P27KIP1 and FHIT, etc., are associated with a decreased risk of adrenomedullary tumors. While no significant difference was found between cell-arrest antigens such as P27KIP1 for malignant, borderline, and benign tumors, there was a significant difference between expression levels of such antigens in normal adrenal medulla samples and in adrenomedullary tumors.Conclusions: Our frame work focused on not only different classification schemes and feature selection algorithms, but also ensemble methods such as boosting and bagging in an effort to improve upon the accuracy of the individual classifiers. It is evident that when all sorts of machine learning and statistically learning techniques are combined appropriately into one integrated intelligent medical decision system, the prediction power can be enhanced significantly. This research has many potential applications; it might provide an alternative diagnostic tool and a better understanding of the mechanisms involved in malignant transformation as well as information that is useful for treatment planning and cancer prevention.

A Cost-Sensitive Classification Strategy and Its Application to Lung Cancer Cell Recognition

Transductive cost-sensitive lung cancer image classification

Classification of Lung Nodules Based on Deep Residual Networks and Migration Learning

Study on computer-aided diagnosis of cytopathological lung cancer

[Implementation and Application of a Digital Cytopathological Lung Cancer Diagnosing System].

Clinical Application of Image Processing and Neural Network in Cytopathological Diagnosis of Lung Cancer

An Explainable Classification Method Based on Complex Scaling in Histopathology Images for Lung and Colon Cancer

Computer-aided diagnosis of lung cancer: the effect of training datasets on classification accuracy of lung nodules.

Coarse-to-Fine Classification via Parametric and Nonparametric Models for Computer-Aided Diagnosis

Computer-aided diagnosis of lung cancer: the effect of training data sets on classification accuracy of lung nodules

A study on specific learning algorithms pertaining to classify lung cancer disease

Lung cancer detection using co-learning from chest CT images and clinical demographics

A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy

An Innovative Method for Lung Cancer Identification Using Machine Learning Algorithms

A combined microfluidic deep learning approach for lung cancer cell high throughput screening toward automatic cancer screening applications

A Hybrid Machine Learning-Based Method for Classifying the Cushing's Syndrome with Comorbid Adrenocortical Lesions

Lung Nodules Detection System Using Support Vector Machine Classifier Combined Linear Discriminant Analysis-Based Feature Selection with Rule-Based Feature Pruning

Computer-aided diagnostic system based on deep learning for classifying colposcopy images

Computer-Aided Lung Cancer Diagnosis Approaches Based on Deep Learning

A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules

Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data